The company was officially incorporated and established
The company's plant building was completed
Register the Aetna Trademark
The Party Branch of Enantiotech was approved for establishment
Expand the pilot plant
A patent is granted for a synthesizing rosuvastatin Intermediates and rosuvastatin
The company passed ISO 9001:2008 quality systemcertification
The company won the first prize of zhongshan science and technology progress awar d and established the 'zhongshan city introduction innovation research team'.
Company won the 'Guangdong Province High-tech Enterprise' certification
The company was identified by Zhongshan Science and Technology Bureau as 'Zhongshan City Asymmetric Catalytic (Enantiotech) Engineering and Technology Research Center'
Finalists in the 5th China Innovation and Entrepreneurship Competition Biopharmaceutical Industry Final
Project 'A preparation method for dibenzoyl and its derivatives' won the second prize of Zhongshan Municipal Government Science and Technology Progress Award
Recognized by the Guangdong Provincial Science and Technology Department as 'Guangdong Province Asymmetric Catalytic (Enantiotech) Engineering and Technology Research Center'
Certification through Intellectual Property Management
A week-long FDA review of our Apster Intermediate DMF approval
Access to the FDA's paper version of the EIR report is an important milestone in the development of our quality management system in Zhongshan
Obtained the 'Research and Development and Industrialization Application of Green Synthetic Catalytic Technology for New Hand Drugs' in Guangdong Province
The establishment of Guangxi Enantiotech Pharmaceutical Co., Ltd. to establish a production base